Pharmicell (005690) — Working Capital to Net Assets Ratio
Pharmicell (005690) has a Working Capital to Net Assets ratio of 63.4% as of September 2025. Working capital of ₩70.03 Billion (current assets of ₩77.16 Billion minus current liabilities of ₩7.13 Billion) is measured against net assets of ₩110.43 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Pharmicell defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Pharmicell Working Capital to Net Assets (2010–2024)
This chart shows how Pharmicell's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2010 to 2024. As of September 2025, the ratio stands at 63.4%, reflecting working capital of ₩70.03 Billion against net assets of ₩110.43 Billion KRW. For the complete balance sheet picture, see Pharmicell assets under control.
Annual Working Capital to Net Assets for Pharmicell (2010–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Pharmicell from 2010 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check how resilient are Pharmicell's assets to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 46.7% | ₩40.39 Billion | ₩86.44 Billion | ₩48.04 Billion | ₩7.65 Billion | ▲ +2.7 pp |
| 2023 | 44.0% | ₩35.40 Billion | ₩80.40 Billion | ₩43.17 Billion | ₩7.76 Billion | ▼ -0.1 pp |
| 2022 | 44.1% | ₩33.82 Billion | ₩76.66 Billion | ₩62.36 Billion | ₩28.55 Billion | ▼ -18.7 pp |
| 2021 | 62.8% | ₩40.10 Billion | ₩63.87 Billion | ₩65.04 Billion | ₩24.94 Billion | ▼ -1.0 pp |
| 2020 | 63.8% | ₩36.43 Billion | ₩57.11 Billion | ₩42.94 Billion | ₩6.51 Billion | ▲ +7.3 pp |
| 2019 | 56.5% | ₩29.13 Billion | ₩51.52 Billion | ₩34.65 Billion | ₩5.53 Billion | ▼ -5.0 pp |
| 2018 | 61.5% | ₩29.21 Billion | ₩47.49 Billion | ₩32.53 Billion | ₩3.32 Billion | ▲ +19.6 pp |
| 2017 | 41.9% | ₩23.47 Billion | ₩55.99 Billion | ₩25.85 Billion | ₩2.38 Billion | ▲ +11.6 pp |
| 2016 | 30.3% | ₩28.71 Billion | ₩94.60 Billion | ₩30.53 Billion | ₩1.82 Billion | ▲ +29.0 pp |
| 2013 | 1.3% | ₩1.09 Billion | ₩82.42 Billion | ₩13.92 Billion | ₩12.83 Billion | ▼ -1.0 pp |
| 2012 | 2.3% | ₩2.32 Billion | ₩101.58 Billion | ₩33.50 Billion | ₩31.18 Billion | ▲ +4.0 pp |
| 2011 | -1.8% | ₩-1.45 Billion | ₩82.82 Billion | ₩15.03 Billion | ₩16.48 Billion | ▲ +27.3 pp |
| 2010 | -29.1% | ₩-2.88 Billion | ₩9.90 Billion | ₩16.29 Billion | ₩19.17 Billion | — |